Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Perfect

Showing results (241-250 of 328) with videos related to

Pageof 33
Sort By:
Mycoses|March 24, 2018
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trialJohn R Perfect, Oliver A Cornely, Markus Heep, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious diseaseLeah E Cowen, Sheena D Singh, Julia R Köhler, et al.
Medical Mycology|November 23, 2023
Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffeiNguyen Thi Mai Thu, Hannah Borda, Shawin Vitsupakorn, et al.
Journal of Medical Microbiology|December 16, 2017
Prevalence, healthcare resource utilization and overall burden of fungal meningitis in the United StatesLefko T Charalambous, Alykhan Premji, Caroline Tybout, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Structures of trehalose-6-phosphate synthase, Tps1, from the fungal pathogen <i>Cryptococcus neoformans</i> : a target for novel antifungalsErica J Washington, Ye Zhou, Allen L Hsu, et al.
The Lancet. Infectious Diseases|April 19, 2021
Cryptococcal meningoencephalitis: time for actionKatharine Elizabeth Stott, Angela Loyse, Joe N Jarvis, et al.
Plos Pathogens|July 30, 2019
Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotypeBenjamin Hommel, Aude Sturny-Leclère, Stevenn Volant, et al.
Infection and Immunity|July 26, 2005
Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfectionKirsten Nielsen, Gary M Cox, Anastasia P Litvintseva, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2019
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal MeningoencephalitisLaura L Kovanda, Charles Giamberardino, Laura McEntee, et al.
Plos Pathogens|September 19, 2019
Correction: Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotypeBenjamin Hommel, Aude Sturny-Leclère, Stevenn Volant, et al.
Pageof 33

Showing results (241-250 of 328) with videos related to

Sort By:
Pageof 33
Mycoses|March 24, 2018
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trialJohn R Perfect, Oliver A Cornely, Markus Heep, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious diseaseLeah E Cowen, Sheena D Singh, Julia R Köhler, et al.
Medical Mycology|November 23, 2023
Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffeiNguyen Thi Mai Thu, Hannah Borda, Shawin Vitsupakorn, et al.
Journal of Medical Microbiology|December 16, 2017
Prevalence, healthcare resource utilization and overall burden of fungal meningitis in the United StatesLefko T Charalambous, Alykhan Premji, Caroline Tybout, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Structures of trehalose-6-phosphate synthase, Tps1, from the fungal pathogen <i>Cryptococcus neoformans</i> : a target for novel antifungalsErica J Washington, Ye Zhou, Allen L Hsu, et al.
The Lancet. Infectious Diseases|April 19, 2021
Cryptococcal meningoencephalitis: time for actionKatharine Elizabeth Stott, Angela Loyse, Joe N Jarvis, et al.
Plos Pathogens|July 30, 2019
Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotypeBenjamin Hommel, Aude Sturny-Leclère, Stevenn Volant, et al.
Infection and Immunity|July 26, 2005
Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfectionKirsten Nielsen, Gary M Cox, Anastasia P Litvintseva, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2019
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal MeningoencephalitisLaura L Kovanda, Charles Giamberardino, Laura McEntee, et al.
Plos Pathogens|September 19, 2019
Correction: Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotypeBenjamin Hommel, Aude Sturny-Leclère, Stevenn Volant, et al.
Pageof 33